✦ LIBER ✦

Sa1524 Pattern and Management of Recurrence in Patients With Barrett's and HGD or Early Cancer Treated With Endoluminal Therapies With Intention to Complete Eradication

✍ Scribed by Carlos Guarner-Argente; Thomas A. Buoncristiano; Gary W. Falk; Gregory G. Ginsberg

Book ID: 119250606
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 79 KB
Volume: 73
Category: Article
ISSN: 1097-6779
DOI: 10.1016/j.gie.2011.03.258

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Sa1525 Long Term Outcomes of Patients Wi

Sa1525 Long Term Outcomes of Patients With Barrett's and HGD or Early Cancer Treated With Endoluminal Therapies With Intention to Complete Eradication

✍ Carlos Guarner-Argente; Thomas A. Buoncristiano; Gary W. Falk; Gregory G. Ginsbe 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 90 KB

What is the accuracy of EUS lymph node s

What is the accuracy of EUS lymph node staging in patients with Barrett's esophagus and high grade dysplasia (HGD) or early cancer (CA)?: A prospective study with implications for endoscopic therapy

📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 136 KB

The use of molecular assays to establish

The use of molecular assays to establish definitively the clonality of ipsilateral breast tumor recurrences and patterns of in-breast failure in patients with early-stage breast cancer treated with breast-conserving therapy

✍ Frank A. Vicini; J. Vito Antonucci; Neal Goldstein; Michelle Wallace; Larry Kest 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 100 KB 👁 1 views

## Abstract ## BACKGROUND. Results from numerous trials have indicated that breast‐conserving therapy (BCT) produces outcomes equivalent to those produced by mastectomy in terms of both locoregional control and survival. However, conservative treatment has resulted in the dilemma of how best to ad